Search - tctmd.com

Displaying 561 - 580 of 832

Sort: Relevancy | Date

Presentation TCT 2016

My Best Alcohol Septal Ablation Case

Presenter: Srihari S. Naidu, Paul Sorajja, George S. Hanzel

October 30, 2016

Presentation TCT 2016

Good and Not So Good Cases to Consider for Alcohol Septal Ablation

Presenter: Srihari S. Naidu, Paul Sorajja, John S. Douglas Jr

October 30, 2016

Presentation TCT 2016

Outcomes and Role of Ablation in the Treatment Approach to Atrial Fibrillation

Presenter: Karl-Heinz Kuck, DJ Lakkireddy, Freek W.A. Verheugt, Vivek Y. Reddy

October 30, 2016

Presentation TCT 2016

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing

Presenter: Bernard J. Gersh, Harry Rakowski, Michael A. Fifer

October 30, 2016

Presentation TCT 2016

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro ICD!

Presenter: Bernard J. Gersh, Harry Rakowski, George S. Hanzel

October 30, 2016

Presentation TCT 2016

When Is Pacing Needed in HCM Outside Invasive Management Settings

Presenter: Bernard J. Gersh, Harry Rakowski

October 30, 2016

Presentation TCT 2016

Medical Management of Non-Obstructive HCM: When and Which Medications?

Presenter: Bernard J. Gersh, Harry Rakowski, John S. Douglas Jr

October 30, 2016

Presentation TCT 2016

Genetic Testing in Hypertrophic Cardiomyopathy: Role in Prognostication and Screening

Presenter: Howard C. Herrmann, Sherif F. Nagueh, Robert Roberts

October 30, 2016

Presentation TCT 2016

Cardiac Catheterization Is Essential for Hemodynamic Assessment

Presenter: Howard C. Herrmann, Sherif F. Nagueh

October 30, 2016

Presentation TCT 2016

Cardiac MR for Diagnosis and Guiding Management of HCM

Presenter: Howard C. Herrmann, Sherif F. Nagueh, Andrew E. Arai

October 30, 2016

Presentation TCT 2016

Echocardiography Essentials for Comprehensive Evaluation of HCM

Presenter: Howard C. Herrmann, Sherif F. Nagueh

October 30, 2016

News Daily News

FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm

Michael O'Riordan

October 11, 2016

News Daily News

Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation

Michael O'Riordan

October 07, 2016

News Industry News

SentreHEART Announces Closing of $35M Funding Round for aMAZE Trial

October 03, 2016

News Conference News ESC 2016

New ESC A-fib Guidelines Call for Integrated Care for All Patients

Todd Neale

August 27, 2016

News Daily News

基因检测不一定是 HCM 诊断的最后一根稻草

Yael L. Maxwell

August 23, 2016

News Daily News

Las Pruebas Genéticas No son Necesariamente la Prueba Concluyente en el Diagnóstico de la CMH

Yael L. Maxwell

August 23, 2016

News Daily News

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

Yael L. Maxwell

August 23, 2016

News Industry News

Biosense Webster, Inc. Announces U.S. Launch of THERMOCOOL SMARTTOUCH® SF Catheter

August 15, 2016

News Daily News

Study Provides More Evidence That Having A-fib Ups Risk of Developing Dementia

L.A. McKeown

July 19, 2016

Advertisement

My Best Alcohol Septal Ablation Case

Good and Not So Good Cases to Consider for Alcohol Septal Ablation

Outcomes and Role of Ablation in the Treatment Approach to Atrial Fibrillation

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro ICD!

When Is Pacing Needed in HCM Outside Invasive Management Settings

Medical Management of Non-Obstructive HCM: When and Which Medications?

Genetic Testing in Hypertrophic Cardiomyopathy: Role in Prognostication and Screening

Cardiac Catheterization Is Essential for Hemodynamic Assessment

Cardiac MR for Diagnosis and Guiding Management of HCM

Echocardiography Essentials for Comprehensive Evaluation of HCM

FDA: ROCKET AF Results Not Affected by Faulty INR Testing in Warfarin Arm

Addition of Biomarkers May Fine Tune Risk Stratification in Atrial Fibrillation

SentreHEART Announces Closing of $35M Funding Round for aMAZE Trial

New ESC A-fib Guidelines Call for Integrated Care for All Patients

基因检测不一定是 HCM 诊断的最后一根稻草

Las Pruebas Genéticas No son Necesariamente la Prueba Concluyente en el Diagnóstico de la CMH

Genetic Testing Not Necessarily the Nail in the Coffin for HCM Diagnosis

Biosense Webster, Inc. Announces U.S. Launch of THERMOCOOL SMARTTOUCH® SF Catheter

Study Provides More Evidence That Having A-fib Ups Risk of Developing Dementia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content